依贝沙坦和阿替洛尔治疗非老年原发性高血压的疗效比较

下载PDF

导出

作者孙延芹钟尹元王长芹王淑芳刘芳钟尚乾

出处《中国药物与临床》 CAS 2002年第2期108-109,共2页 Chinese Remedies & Clinics

关键词非老年原发性高血压依贝沙坦阿替洛尔药物疗法疗效比较

参考文献7

1Messerli FH,Weber MA.Brunner HR.Angiotensin Ⅱ receptor inhibition:a new therapeutic.Arch Intern Med,1996,156(11):1957-1965.
2钟尹元,孙延芹,张泽春,等.心脑肾病合理选药.济南:黄河出版社,1966.12-42.
3Goldberg AL.Dunlay MC,Sweet CS.Safety and tolerability of losartan potassium,compared with hydrochlorothiazide,atenolol,felodipine and ACEI for the treatment of systemic hypertension.Am J Cardiol,1995,75(6):793-795.
4Dahlof B,Devereux RB,Julius S,et al.Characteristics of 9 194 patients with left ventricular hypertrophy:the life study losartan intervention for endpoint reduction on hyperten-sion.Hypertension,1988,32(3):989-997.
5Marino MR,Langenbacher KM,Ford NF,et al.Safety,tolariility,pharmacokinetics and pharmacodynamics of irbesartan after single and multiple dose in healthy males subjects.Clin Pharmacol Ther,1997,6(2):207-209.
6Pluleur HG.Clinical overview of irbesartan:a new angiotensin Ⅱ receptor antagonist.Am J Hypertens,1997,10(2):318-324.
7Kassler-Taub K,Littlejohn T,Elliott W,et al.Comparative efficacy of two angiotensin Ⅱ receptor antagonists,irbesartan and losartan,in mild-to-moderate hypertension.Am J Hypertens,1998,11(3):445-453.

中国药物与临床

2002年第2期

内容加载中请稍等...